• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters

tetano

Editor, Senior Moderator
Front Immunol


. 2024 Mar 18:15:1285278.
doi: 10.3389/fimmu.2024.1285278. eCollection 2024. Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters

Bethany Girard[SUP] 1 [/SUP], Elisabeth Baum-Jones[SUP] 2 [/SUP], Rebecca L Best[SUP] 2 [/SUP], Thomas W Campbell[SUP] 2 [/SUP], Jack Coupart[SUP] 2 [/SUP], Kyla Dangerfield[SUP] 2 [/SUP], Abhilash Dhal[SUP] 2 [/SUP], Michael Jhatro[SUP] 2 [/SUP], Brian Martinez[SUP] 2 [/SUP], Jack Reifert[SUP] 2 [/SUP], John Shon[SUP] 2 [/SUP], Minlu Zhang[SUP] 2 [/SUP], Rebecca Waitz[SUP] 2 [/SUP], Spyros Chalkias[SUP] 1 [/SUP], Darin K Edwards[SUP] 1 [/SUP], Maha Maglinao[SUP] 1 [/SUP], Robert Paris[SUP] 1 [/SUP], Rolando Pajon[SUP] 1 [/SUP]



Affiliations
Abstract

Background: Characterizing the antibody epitope profiles of messenger RNA (mRNA)-based vaccines against SARS-CoV-2 can aid in elucidating the mechanisms underlying the antibody-mediated immune responses elicited by these vaccines.
Methods: This study investigated the distinct antibody epitopes toward the SARS-CoV-2 spike (S) protein targeted after a two-dose primary series of mRNA-1273 followed by a booster dose of mRNA-1273 or a variant-updated vaccine among serum samples from clinical trial adult participants.
Results: Multiple S-specific epitopes were targeted after primary vaccination; while signal decreased over time, a booster dose after >6 months largely revived waning antibody signals. Epitope identity also changed after booster vaccination in some subjects, with four new S-specific epitopes detected with stronger signals after boosting than with primary vaccination. Notably, the strength of antibody responses after booster vaccination differed by the exact vaccine formulation, with variant-updated mRNA-1273.211 and mRNA-1273.617.2 booster formulations inducing significantly stronger S-specific signals than a mRNA-1273 booster.
Conclusion: Overall, these results identify key S-specific epitopes targeted by antibodies induced by mRNA-1273 primary and variant-updated booster vaccination.

Keywords: COVID-19; SARS-CoV-2; antibody profile; dosing regimen; mRNA-1273.

 
Back
Top Bottom